Bendamustine 100mg Injection Bimode

Non-Hodgkin lymphoma is treated with Bendamustine 100mg Injection Bimode. CLL stands for chronic lymphocytic leukemia.

Bendamustine 100mg Injection Bimode is administered in a variety of ways. Bendamustine is administered as an intravenous infusion. A healthcare provider will administer this injection to you. Every 21 to 28 days, bendamustine is commonly taken for two days in succession.

Bendamustine 100mg Injection Bimode may increase your risk of developing progressive multifocal leukoencephalopathy, a dangerous and rare brain infection (PML). If you have weakness on one side of your body, clumsiness, hazy vision, changes in your thinking, memory issues, disorientation, or personality changes, consult your doctor.

Weakness and exhaustion
During your treatment, you may become extremely exhausted. After the treatment, it may take 6 months to a year for your energy levels to return to normal. You will feel fatigued if your red blood cell count is low. You can aid yourself by doing things like mild exercise.

Hair loss occurred in one of the 153 patients treated with bendamustine hydrochloride in a clinical study for CLL, compared to 0 (zero) of the 143 patients treated with chlorambucil. Hair loss was observed in three of the 100 individuals treated with bendamustine hydrochloride in an NHL research.

This drug is used to treat a variety of cancers (such as lymphoma, and chronic lymphocytic leukemia – CLL). Bendamustine is an alkylating agent, which is a type of cancer chemotherapeutic medication. It acts by either destroying or delaying the growth of cancer cells.

People who take this medicine have experienced heart complications such as heart failure. This has sometimes resulted in death. If you have chest pain or pressure, a heartbeat that does not seem normal, shortness of breath, a significant weight increase, or swelling in your arms or legs, call your doctor immediately. 

Bendamustine is known to cause rash, itching, fever, and chills in some people. This reaction isn’t usually serious.

Bendamustine has been found in multiple drug databases as an irritant with vesicant-like characteristics. Some sources classify it as an irritant, but the ESMO-EONS 2012 guideline classifies it as a vesicant.

Check out this Anti Cancer product MyMust 100mg Injection or you may explore more Anti Cancer products by clicking here 

We are an exporter from India and work in many countries, such as the UAE, Oman, Qatar, Myanmar, Saudi Arabia, the Netherlands, Albania, Saint Lucia, Jordan, Romania, and South Africa.